Targeting TCTP as a New Therapeutic Strategy in Castration-Resistant Prostate Cancer

Molecular Therapy - United States
doi 10.1038/mt.2012.155
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer

Clinical Cancer Research
Cancer ResearchOncology
2015English

LINE-1 as a Therapeutic Target for Castration-Resistant Prostate Cancer

Frontiers in Bioscience - Landmark
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2018English

Ailanthone: A New Potential Drug for Castration-Resistant Prostate Cancer

Chinese Journal of Cancer
2017English

Castration-Resistant Prostate Cancer: A Strategy to Enhance Response to Androgen Deprivation

Asian Journal of Andrology
MedicineUrology
2013English

Targeting the MIF/CXCR7/AKT Signaling Pathway in Castration-Resistant Prostate Cancer

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2018English

STAT3 and STAT5A Are Potential Therapeutic Targets in Castration-Resistant Prostate Cancer

Oncotarget
Oncology
2017English

Emerging Role of Glucocorticoid Receptor in Castration Resistant Prostate Cancer: A Potential Therapeutic Target

Journal of Cancer
Oncology
2020English

Visceral Disease in Castration-Resistant Prostate Cancer

European Urology
Urology
2014English

Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer

Yearbook of Paediatric Endocrinology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy